home / stock / aim / aim articles

AIM Articles, AIM ImmunoTech Inc.

Stock Information
Company Name: AIM ImmunoTech Inc.
Stock Symbol: AIM
Market: NYSE
Website: aimimmuno.com
Menu
AIM AIM Quote AIM Short AIM News AIM Articles AIM Message Board
Get AIM Alerts

News, Short Squeeze, Breakout and More Instantly...
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference | Benzinga

OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), today announced that Thomas K. Equels, ...
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series | Benzinga

OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), today announced that Thomas K. Equels, ...

AIM ImmunoTech to Participate in Two Upcoming Investor Conferences | Benzinga

OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that AIM Chief Executive ...

AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update | Benzinga

Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Compa...
AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast | Benzinga

OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") announced today that management will host...

AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs | Benzinga

OCALA, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM") today announced that Charles Lapp, MD, is joining the co...

AIM ImmunoTech Announces Release of the Next CEO Corner Segment | Benzinga

OCALA, Fla., April 11, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), today announced the next CEO Corner se...
AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | Benzinga

Year marked by growing body of promising data demonstrating Ampligen's potential to address multiple high-value indications Company to host c...

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference | Benzinga

OCALA, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that Thomas K. Equels, ...

AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying | Benzinga

The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern arou...
Next 10